The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients
Launched by MAHIDOL UNIVERSITY · Sep 25, 2018
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cancer patients who follow up as out patient at pain clinic, Siriraj hospital
- • Age older than 18 years old
- • Fluently read, write and speak in Thai language
- • No cognitive impairment
- Exclusion Criteria:
- • Unstable clinical presentation
- • Severe pain or pain numerical rating scale more than 7
- • Severe associated symptoms such as nausea, vomiting
- • The patient who do not know their diagnosis
About Mahidol University
Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkoknoi, Bangkok, Thailand
Patients applied
Trial Officials
Suratsawadee Wangnamthip, MD
Principal Investigator
Lecturer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials